Evidence map›Paper›PMID 31523624›Full record

ArticleBalkan journal of medical genetics : BJMG2019

Impact of Genetics on Neoadjuvant Therapy with Complete Pathological Response in Metastatic Colorectal Cancer: Case Report and Review of the Literature.

P Bulajic, N Bidzic, V Djordjevic, Μ Ceranic, D Βasaric, V Pesic, J Djordjevic-Pesic

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Balkan journal of medical genetics : BJMG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

P BulajicClinic for Digestive Surgery, The First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia.
N BidzicClinic for Digestive Surgery, The First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia.
V DjordjevicClinic for Digestive Surgery, The First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia.
Μ CeranicClinic for Digestive Surgery, The First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia.
D ΒasaricClinic for Digestive Surgery, The First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia.
V PesicUniversity of Belgrade, Faculty of Agriculture, Department of Genetics, Belgrade, Serbia.
J Djordjevic-PesicMedical School "Dr. Milenko Hadzic," Nis, Belgrade, Serbia.
University of Nis · RSCentar za Promociju Nauke · RSUniversity of Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of colorectal metastatic cancer is still challenging, despite recent improvements in chemotherapy. A genetic cancer profile, such as the

Indexed as

BevacizumabKRAS (Kirsten rat sarcoma) gene mutationMetastatic colorectal cancerPathological complete responseVanishing metastases

Identifiers

PMID31523624
PMCPMC6714337
OpenAlexW2970545193

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.